Picard Medical, Inc.
Capital Structure and Liquidity Picard Medical, Inc. has a negative total equity of -$1.45 million and a current ratio of 0.75, indicating that current liabilities exceed current assets. The company's liquidity is assessed as high, but its cash and equivalents amount to only $121,000, which is significantly lower than its operating cash flow of -$3.8 million and free cash flow of -$3.83 million. The market cap is $16.63 million, with a market price of $0.22 per share. ## Profitability and Returns The company reported a net loss of $7.62 million for Q1 2026, with an operating loss of $4.51 million. The return on equity is 5.26%, while the return on assets is -0.68%, indicating poor asset utilization. The company's gross profit is $275,000, but this is overshadowed by its significant operating and net losses. ## Segments and Geographic Exposure Picard Medical, Inc. operates in the insurance and brokerage sector, with a focus on multiline insurance. The company's revenue is primarily concentrated in the United States, with some exposure to Europe and other foreign countries. However, the exact revenue concentration by segment and geography is not disclosed in the provided data. ## Growth Trajectory The company's revenue for Q1 2026 is $1.15 million, but it is not clear from the data whether this represents growth or a decline compared to previous periods. The company's outlook for the current and next fiscal years is not provided, but the significant net loss and negative cash flows suggest a challenging growth trajectory. ## Risk Factors The company faces several risk factors, including a going-concern issue, substantial doubt about its ability to continue as a going concern, and potential dilution from future offerings. The risk assessment indicates medium dilution potential, and the company has a high liquidity risk due to its negative equity and current liabilities exceeding current assets. ## Recent Events Recent events include the filing of a Form 10-Q for Q1 2026, which includes forward-looking statements and a discussion of various risks and uncertainties. The company has also issued convertible notes and warrants, and there are subsequent events related to the conversion of senior secured notes into common stock and the issuance of new warrants.
Business. Picard Medical, Inc. (PMI) is a multiline insurance and brokers company that provides insurance products and services to clients, generating revenue primarily through premiums and fees from insurance policies and brokerage services.
Classification. Picard Medical, Inc. is classified under the Financials sector, specifically in the Insurance business sector and the Insurance industry, with a classification confidence of 0.92 based on rule-based classification.
- Picard Medical, Inc. has a negative total equity and a current ratio below 1, indicating significant liquidity and solvency risks.
- The company reported a substantial net loss and operating loss for Q1 2026, with poor returns on equity and assets.
- The company's revenue is primarily concentrated in the United States, with some exposure to Europe and other foreign countries.
- The company faces significant risk factors, including going-concern issues, potential dilution, and regulatory and operational challenges.
- Recent events include the issuance of convertible notes and warrants, and subsequent events related to the conversion of senior secured notes into common stock.
- --
- # RATIONALES
- ```json
- Current liabilities exceed current assets.
- Filings reference going-concern or substantial-doubt language.
- Source documents mention dilution or offering risk.